Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-20

Clinical Trial Update: Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Enstilar Foam for chronic plaque psoriasis in patients with skin of color; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enstilar Foam

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Plaque Psoriasis, Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2021-01-20